Coronary revascularization and use of hemodynamic support in acute coronary syndromes
Cardiogenic shock develops in up to 10% of patients with acute myocardial infarction and continues to have high mortality. Early invasive treatment is the default therapeutic approach in these patients. On the basis of the results of the CULPRIT-SHOCK trial, culprit-only revascularization during the...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2019
|
| Sorozat: | HELLENIC JOURNAL OF CARDIOLOGY
60 No. 3 |
| doi: | 10.1016/j.hjc.2019.01.010 |
| mtmt: | 30594201 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/17179 |
| Tartalmi kivonat: | Cardiogenic shock develops in up to 10% of patients with acute myocardial infarction and continues to have high mortality. Early invasive treatment is the default therapeutic approach in these patients. On the basis of the results of the CULPRIT-SHOCK trial, culprit-only revascularization during the acute phase is preferred over multivessel revascularization. Routine use of intra-aortic balloon pump (IABP) is not recommended; however, the use of mechanical circulatory support has been increasing despite limited observational data to support its use. Several studies support multivessel revascularization in patients with uncomplicated ST-segment elevation acute myocardial infarction and simple nonculprit lesions to improve subsequent clinical outcomes. |
|---|---|
| Terjedelem/Fizikai jellemzők: | 165-170 |
| ISSN: | 1109-9666 |